Stay updated on Fruquintinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib in Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedThe study record page now shows a 403 Forbidden error instead of the study details, replacing the content with a standard error page.SummaryDifference21%

- Check8 days agoChange DetectedThe revision label on the page updated from v3.6.6 to v3.7.0, indicating a newer page revision. This reflects an update to the document/versioning rather than to the study data.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedA new site revision number appears as v3.6.6, replacing the previous v3.6.5.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, indicating a new revision of the page content. This change updates the documented version of the page in the revision history.SummaryDifference0.0%

- Check64 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3 to reflect a small update to the page's version.SummaryDifference0.0%

- Check86 days agoChange DetectedThe page now displays Revision: v3.6.3, replacing the previous v3.6.0. This indicates a newer version of the page template or content, with no user-facing study information changed.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib in Solid Tumors Clinical Trial page.